Redacción Médica analiza las disimilitudes entre la eficacia, el tiempo de protección o su conservación, entre otros Estados Unidos ya ha aprobado la vacuna de Janssen contra el Covid-19 para su uso de emergencia. La compañía farmacéutica suministrará hasta 200 millones de dosis a la Unión Europea a lo largo de 2021. Hasta […]
Read More
Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective with 91.3% vaccine efficacy observed against COVID-19, measured seven days through up to six months after the second dose Vaccine was 100% effective in preventing severe disease as defined by the U.S. Centers for Disease Control and […]
Read More
Pfizer and BioNTech have asked the US Food and Drug Administration (FDA) to expand authorization of their COVID vaccine to include children as young as 12 years of age. The companies said they plan to ask for similar rulings by other regulatory bodies around the world in coming days. The request follows […]
Read More
Vaccination with the Pfizer or Moderna vaccine reduces infections by 90%, while a single dose confers 80% protection, shows a study led by the US Centers for Disease Control and Prevention (CDC) that followed essential workers through the worst months of the pandemic. The study is one of a small […]
Read More
The Pfizer Inc.-BioNTech SE vaccine remained highly effective against Covid-19 after six months, according to new long-term results that Pfizer said could be used to seek an expansion of the shot’s regulatory status. Follow-up data from a final-stage trial of 46,307 people showed the vaccine was 91.3% effective in preventing […]
Read More
Nueva York,.- Las farmacéuticas Pfizer y BioNTech informaron este jueves de que su vacuna contra Covid-19 sigue siendo altamente efectiva durante al menos seis meses después de administrarse la segunda dosis y que además funciona contra la variante sudafricana del virus. Las conclusiones proceden de un seguimiento de los voluntarios […]
Read More
Phase III clinical trials show that Pfizer’s coronavirus vaccine is 100% effective in protecting children 12-15 years old from infection, the company said in a news release. The study enrolled 2,260 adolescents ages 12-15. No infections were reported in the group given the vaccine produced by Pfizer and its European […]
Read More
People previously infected with SARS-CoV-2 showed higher antibody and T-cell responses after one dose of Pfizer’s BNT162b2 messenger (mRNA) vaccine compared with people who had a first dose without previously contracting the virus, according to research led by the universities of Sheffield and Oxford. The early findings from the Protective […]
Read More
Un grupo científico concluye que este fármaco podría reducir “sustancialmente” la carga viral en la infección irruptiva Más allá de ofrecer una protección sustancial frente al SARS-CoV-2, las vacunas contra la enfermedad de la Covid-19 podrían reducir carga viral en la infección irruptiva y, por lo tanto, suprimir aún más […]
Read More
Un nuevo estudio analizó los efectos de la vacuna en 237 trabajadores de la salud Un nuevo estudio que analizó el efecto de la vacuna contra el coronavirus de Pfizer / BioNTech descubrió que casi todos los receptores generaron una respuesta inmune “robusta” después de una sola dosis. La investigación […]
Read More